Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Suk Bae Moon & Sang Beom Han. (2017) Efficacy and safety of fixed-combination bimatoprost/timolol ophthalmic solution. Patient Preference and Adherence 11, pages 1069-1070.
Read now
Read now
Articles from other publishers (5)
Xinghuai Sun, Ke Yao, Qinghuai Liu, Hong Zhang, Xiaoli Xing, Aiwu Fang, Xuanchu Duan, Minbin Yu, Michelle Y. Chen, Jingyuan Yang & Margot L. Goodkin. (2022) Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and Therapy 12:1, pages 341-353.
Crossref
Crossref
Jingchao Yan, Xiaomei Xiong, Jianwen Shen & Taomin Huang. (2021) The use of fixed dose drug combinations for glaucoma in clinical settings: a retrospective, observational, single-centre study. International Ophthalmology 42:3, pages 945-950.
Crossref
Crossref
Philippe Denis, Susana Duch, Enping Chen, Per Klyve, Jesper Skov, Païvi Puska & Carl Erb. (2020) European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment. European Journal of Ophthalmology 31:3, pages 1056-1063.
Crossref
Crossref
Xingqi Wang, Yong Zhang, Jie Huang, Mengqiu Xia, Liu Liu, Chunling Tian, Rongfeng Hu, Shuangying Gui & Xiaoqin Chu. (2019) Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate. International Journal of Pharmaceutics 562, pages 31-41.
Crossref
Crossref
Xinghuai Sun & Yi Dai. 2019. Medical Treatment of Glaucoma. Medical Treatment of Glaucoma
217
219
.